Skip to main content

Advertisement

ADVERTISEMENT

Prostate Cancer Videos

Abiraterone vs Docetaxel for De Novo Prostate Cancer in Real-World and Trial Settings
Videos
03/18/2021
Daniel Geynisman, MD, discusses results from a study which compared real-world survival among men with de novo metastatic prostate cancer treated with abiraterone acetate or docetaxel and compared these outcomes to those seen in clinical...
Daniel Geynisman, MD, discusses results from a study which compared real-world survival among men with de novo metastatic prostate cancer treated with abiraterone acetate or docetaxel and compared these outcomes to those seen in clinical...
Daniel Geynisman, MD, discusses...
03/18/2021
Journal of Clinical Pathways

Advertisement

Real-World Treatment Patterns, Survival Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Videos
02/25/2021
Stephen Freedland, MD, discusses study results exploring real-world evidence on survival outcomes among men with metastatic castration-resistant prostate cancer who initiated ADT or ADT combined with anti-androgens, docetaxel, or abiraterone.
Stephen Freedland, MD, discusses study results exploring real-world evidence on survival outcomes among men with metastatic castration-resistant prostate cancer who initiated ADT or ADT combined with anti-androgens, docetaxel, or abiraterone.
Stephen Freedland, MD, discusses...
02/25/2021
Journal of Clinical Pathways
Hospital Efficiency Impact on Quality of Prostate Cancer Care
Videos
02/24/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement